HIGHLIGHTS
- who: Sen Lin from the Department of General Surgery, People's Liberation Army Navy , Hospital, Qingdao, Shandong, China have published the paper: Effects of Apatinib Mesylate Monotherapy on the Incidence of Adverse Reactions and Immune Function in Patients with Breast Cancer after Radical Mastectomy, in the Journal: Evidence-Based Complementary and Alternative Medicine of 10/08/2022
- what: In view of the lack of reports, the aim of this study was to assess the effect of monotherapy with Apatinib Mesylate on the incidence of adverse events and immune function after radical mastectomy in breast cancer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.